Skip to content
Open in App
Abrdn Life Sciences Investors logo

Abrdn Life Sciences Investors

web2

abrdn Life Sciences Investors is a closed end investment fund seeking long term capital appreci...

Symbol · HQL
Company profile

About

abrdn Life Sciences Investors is a closed end investment fund seeking long term capital appreciation through equity investments in companies involved in healthcare and life sciences. Its portfolio includes publicly traded and privately held businesses developing or supplying biotechnology products, pharmaceuticals, diagnostic technologies, medical equipment and healthcare services. The investment mandate also encompasses selected scientific applications in agriculture and environmental management. The fund can hold restricted securities, including investments in companies that are not publicly listed. Structured as a Massachusetts business trust, it is managed by Aberdeen and its common shares trade on the New York Stock Exchange under the symbol HQL.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

ExchangeNYSEPrimary symbol: HQL
Expert coverage

1 expert evaluated Abrdn Life Sciences Investors.

Orbitrum research

Experts evaluating Abrdn Life Sciences Investors

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment